Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals

Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health collaboration will create a seamless, integrated experience between abbott's world-leading continuous glucose monitoring device1 and weightwatchers' number one doctor-recommended weight loss program2 to help individuals better understand and manage their diabetes and weight abbott park, ill., aug. 4, 2022 /prnewswire/ -- abbott (nyse: abt) and ww international, inc. ("weightwatchers" or "ww") today announced a strategic partnership that will help people living with diabetes better understand and manage their diabetes and weight.
ABT Ratings Summary
ABT Quant Ranking